|Issuer:||SORRENTO THERAPEUTICS, INC. (SRNE)|
|Original Submission Date:|
C/O SORRENTO THERAPEUTICS, INC.
4955 DIRECTORS PLACE SAN DIEGO, CA 92121
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|STOCK OPTION (RIGHT TO BUY)||6.01||2021-11-18||deemed execution date||A||100,000 (a)||2031-11-18||common stock 100,000||$6.01||100,000||direct|
|f1||1/12th of the original number of shares subject to the option shall vest on december 18, 2021, and 1/12th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the reporting person's continued service to the issuer through each such vesting date.|